Patent · US Active

Insulin delivery methods, systems and devices

US11027063B2 · kind B2 · utility

7Cited by
100References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 12, 2018
Grant dateJun 8, 2021
Priority date
Expiry dateJan 26, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2230/201
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An insulin delivery monitoring system that includes an insulin delivery device and a controller configured to perform or control performance of operations. A method of insulin delivery include determining a correction dose of insulin and triggering an alert.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.